Market Tracker

12/19 4:50am ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.94
Data as of Dec 18
 +0.20 / +2.29%
Today’s Change
6.52
Today|||52-Week Range
11.47
+18.57%
Year-to-Date

Today’s Trading

Previous close8.74
Today’s open8.83
Day’s range-- - --
Volume696,592
Average volume (3 months)413,338
Market cap$375.2M
Dividend yield--
Data as of 12/18/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+103.62%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.44

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...-0.07-0.72%
VTAEVitae Pharmaceutical...+0.64+2.98%
DVAXDynavax Technologies...----
RVNCRevance Therapeutics...+0.30+1.77%
Data as of 12/18/2014

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts